results are best when combined with proper nutrition, sleep, and rehabilitation
Notably, although GLP-1 agonists do not independently cause hypoglycemia, their combination with other glucose-lowering drugs may pose a risk, which is compounded in psychiatric patients who may struggle to manage their blood sugar or recognize symptoms of hypoglycemia
This start enhances satiety signals, reduces food intake, and may increase response to other satiety hormones like leptin
That is why screening, monitoring, and dose adjustment are part of every plan
Statistical significance is tested at 5% level, with no correction for multiple testing
Toepfer, C